Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by Paparico1on Mar 20, 2018 1:57pm
120 Views
Post# 27747884

RE:RE:If your not sure

RE:RE:If your not sure
???????????? if they have nothing why would why be doing this 2018-03-20 10:24 ET - News Release Mr. John Rucci reports VOYAGEUR MINERALS LTD. AND INNOVATION METALS CORP. SIGN MOU FOR WORLDWIDE RIGHTS TO HIGH-PURITY BARITE TECHNOLOGY Voyageur Minerals Ltd. has signed a non-binding memorandum of understanding with Innovation Metals Corp. to access Innovation's proprietary processing technology for the production of high-purity barium sulphate. Innovation Metals is a private Ontario-based company that develops cost-effective separation and purification processes for the critical materials industry. "With this innovative technology, VM will be able to direct its future barite production towards the highest-value customers within the high-end industrial barite market space," said John Rucci, president and chief executive officer of Voyageur. "Today, 100 per cent of high-purity barite in the U.S. and Canada rely on foreign imports, primarily from China. With access to this new technology, Voyageur moves forward with its goal of providing customers with a local source of multiple industrial grades." The Innovation technology will allow Voyageur to produce consistent high-grade barite suitable for multiple industrial grades, including the pharmaceutical market and high-end filler markets, including reagents, paints and plastics. "The U.S. government considers barite to be a mineral of critical and strategic importance to U.S. national and economic security," commented Gareth Hatch, president of Innovation, "As most recently embodied in Executive Order 13817 issued on Dec. 20, 2017, by President Trump. We look forward to working with Voyageur Minerals to bring North American sources of this important mineral to the market." Production plant On completion of pilot-scale testing, a commercial-scale demonstration plant will be built, capable of producing 2,000 tonnes per year of high-purity barite. Production will initially begin from a 10,000-tonne bulk sample. After the demo plant is completed and tested, Voyageur plans to increase production to 6,000 to 10,000 tonnes per year. The company has been working with Innovation to test the technology and initial results indicate that pharmaceutical-grade barite (99.5 per cent plus purity) can consistently be achieved. Pharmaceutical-grade barite currently sells for between $2,800 (U.S.) and $7,500 (U.S.) per tonne (FOB China). Voyageur is in discussions with a number of key players in the pharmaceutical and high-end barite industry. As the company advances the project, it will work to secure potential off-take supply agreements. Any cash flow from operations will finance continued exploration of Voyageur barite deposits, focusing on expanding potential resources. Voyageur will also utilize cash flow for the further development of the company's lithium projects in Utah. Terms of MOU and proposed joint venture The MOU proposes the creation of a joint venture company between Voyageur and Innovation. Following completion of pilot-scale testing, Voyageur will finance the construction of the demo plant, with the JV structured to give Voyageur 75-per-cent- and Innovation 25-per-cent-ownership of the JV. Once the JV has achieved mutually agreed minimum production rates, Voyageur will have the right to buy Innovation's 25-per-cent ownership of the JV at fair market value. If Voyageur buys out the 25-per-cent Innovation interest, Innovation will retain a 1-per-cent net profit royalty, which can also be purchased by Voyageur for $1-million for up to five years after commercial-scale production commences.
Bullboard Posts